Detecting prostate cancer earlier, can improve treatment outcomes and lower the likelihood that the cancer will metastasis, or spread. By investing in advanced prostate cancer detection and screening initiatives, Albertans are living longer and avoiding potentially unnecessary treatments.
Each year, thousands of Canadians undergo biopsies to detect prostate cancer and monitor disease progression. To increase the effectiveness of prostate cancer screening, ensuring test accuracy is paramount.
Thanks to your support, the Alberta Prostate Cancer Research Initiative (APCaRI) – a multi-disciplinary team of more than 100 prostate cancer professionals- is working hard to develop new and more accurate tests for detecting and treating prostate cancer.